Press Releases

Featured Press Releases

John F. Crowley, President and CEO of the…

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…

Learn more

BIO Statement on National Security Commission on…

WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…

Learn more

BIO Statement on Resignation of Peter Marks from…

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…

Learn more

PASTEUR Act is Promising Bipartisan Reform, Will Strengthen Antimicrobial Development

June 16, 2021

Today, Congress introduced the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act, which proposes a new approach to drive increased private sector investment & improve financial stability in the market for…

Maryland Governor Larry Hogan Named BIO’s Governor of the Year

June 15, 2021

Today, the Biotechnology Innovation Organization (BIO) presented Maryland Governor Larry Hogan with its 2021 Governor of the Year Award. Governor Hogan received the award virtually at BIO Digital 2021. With the annual award, BIO honors governors…

Agriculture Secretary Tom Vilsack to Discuss Access and Equality at BIO Digital

June 13, 2021

With only one day until BIO Digital, the Biotechnology Innovation Organization (BIO) continues to add to its impressive line-up of featured speakers. Today, BIO announced that U.S. Agriculture Secretary Tom Vilsack will join BIO President and CEO Dr…

BIO Elects Paul Hastings as New Board Chair

June 11, 2021

New Officers Join BIO’s Governing Boards

BIO Takes on Health Equity in Clinical Trials

June 10, 2021

First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem

BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations

May 18, 2021

"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…

BIO Extends Agreement with Avantor

May 10, 2021

Today, the Biotechnology Innovation Organization (BIO) announced an extension through June 2029 to its established agreement with Avantor. Through this agreement, members across North America have access to a broad…

Support of "TRIPS" Waiver Sets Dangerous Precedent

May 5, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…

Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs

May 4, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…

BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH

May 3, 2021

Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.